2143 related articles for article (PubMed ID: 19998744)
1. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
2. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
3. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
4. Import for export; reporting and recordkeeping requirements for unapproved or violative products imported for further processing or incorporation and subsequent export--FDA. Proposed rule.
Fed Regist; 1998 Nov; 63(226):64930-7. PubMed ID: 10338872
[TBL] [Abstract][Full Text] [Related]
5. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
[TBL] [Abstract][Full Text] [Related]
6. Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice.
Fed Regist; 1998 Jun; 63(113):32219-34. PubMed ID: 10180275
[TBL] [Abstract][Full Text] [Related]
7. Medical devices; humanitarian use of devices--FDA. Direct final rule.
Fed Regist; 1998 Apr; 63(74):19185-90. PubMed ID: 10178430
[TBL] [Abstract][Full Text] [Related]
8. Medical device labeling and advertising: an overview.
Basile EM; Armentrout E; Reeves KN
Food Drug Law J; 1999; 54(4):519-33. PubMed ID: 11824451
[TBL] [Abstract][Full Text] [Related]
9. Medical devices; reports of corrections and removals--FDA. Direct final rule.
Fed Regist; 1998 Aug; 63(152):42229-33. PubMed ID: 10181725
[TBL] [Abstract][Full Text] [Related]
10. Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Apr; 65(71):19650-8. PubMed ID: 11010632
[TBL] [Abstract][Full Text] [Related]
11. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
Alder HC
Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
[TBL] [Abstract][Full Text] [Related]
12. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
[TBL] [Abstract][Full Text] [Related]
13. Medical devices; reconditioners, rebuilders of medical devices; revocation of compliance policy guide; request for comments--FDA. Notice.
Fed Regist; 1998 Dec; 63(233):67076-8. PubMed ID: 10338883
[TBL] [Abstract][Full Text] [Related]
14. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
Fed Regist; 1998 Apr; 63(80 Pt 1):20530-3. PubMed ID: 10179319
[TBL] [Abstract][Full Text] [Related]
15. Investigational new drugs: export requirements for unapproved new drug products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2005 Nov; 70(225):70720-30. PubMed ID: 16304736
[TBL] [Abstract][Full Text] [Related]
16. Guidance of FDA's expectations of medical device manufacturers concerning the year 2000 date problem--FDA. Notice.
Fed Regist; 1998 Jun; 63(121):34433-42. PubMed ID: 10180297
[TBL] [Abstract][Full Text] [Related]
17. Medical devices; medical device reporting; baseline reports. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jun; 73(115):33692-5. PubMed ID: 18677824
[TBL] [Abstract][Full Text] [Related]
18. Medical devices; device tracking; new orders to manufacturers--FDA. Notice.
Fed Regist; 1998 Mar; 63(42):10638-40. PubMed ID: 10177504
[TBL] [Abstract][Full Text] [Related]
19. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
20. FDA policy on unapproved drug products: past, present, and future.
Chhabra R; Kremzner ME; Kiliany BJ
Ann Pharmacother; 2005; 39(7-8):1260-4. PubMed ID: 15956239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
